Fecal incontinence and scleroderma: Pathogenesis and unmet needs
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 35 (3) , 101686
Abstract
No abstract availableKeywords
Funding Information
- Manchester Biomedical Research Centre
- Kennedy Trust for Rheumatology Research
This publication has 20 references indexed in Scilit:
- Sacral nerve stimulation for the treatment of faecal incontinence following low anterior resection for rectal cancerColorectal Disease, 2010
- Geoepidemiology of systemic sclerosisAutoimmunity Reviews, 2010
- Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Patient perception of UK scleroderma services--results of an anonymous questionnaireRheumatology, 2006
- Artificial anal sphincterDiseases of the Colon & Rectum, 2000
- Safety and efficacy of dynamic graciloplasty for fecal incontinenceDiseases of the Colon & Rectum, 2000
- Bowel Problems in Patients with Systemic SclerosisScandinavian Journal of Gastroenterology, 1999
- Anorectal function in systemic sclerosisDiseases of the Colon & Rectum, 1997
- Investigation of anal function in patients with systemic sclerosis.Annals of the Rheumatic Diseases, 1996
- Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence.Gut, 1994